AssetMark Inc’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Buy
28,230
+4,433
+19% +$49.5K ﹤0.01% 1375
2026
Q1
$258K Buy
23,797
+1,786
+8% +$15.3K ﹤0.01% 1293
2025
Q4
$134K Buy
22,011
+13,084
+147% +$78.1K ﹤0.01% 1402
2025
Q3
$46.2K Buy
8,927
+444
+5% +$2.55K ﹤0.01% 1659
2025
Q2
$50.3K Sell
8,483
-9
-0.1% -$54 ﹤0.01% 1565
2025
Q1
$69.8K Sell
8,492
-1,655
-16% -$13.9K ﹤0.01% 1360
2024
Q4
$83.8K Sell
10,147
-648
-6% -$5.2K ﹤0.01% 1287
2024
Q3
$82.6K Buy
10,795
+5
+0% +$46 ﹤0.01% 1180
2024
Q2
$112K Buy
10,790
+335
+3% +$3.67K ﹤0.01% 1092
2024
Q1
$125K Sell
10,455
-736
-7% -$8.18K ﹤0.01% 1031
2023
Q4
$121K Buy
11,191
+463
+4% +$5.63K ﹤0.01% 1003
2023
Q3
$148K Buy
10,728
+9,728
+973% +$142K ﹤0.01% 925
2023
Q2
$12K Hold
1,000
﹤0.01% 1275
2023
Q1
$11.7K Hold
1,000
﹤0.01% 1256
2022
Q4
$16.8K Hold
1,000
﹤0.01% 1232
2022
Q3
$12K Hold
1,000
﹤0.01% 1206
2022
Q2
$16K Buy
+1,000
New +$16.8K ﹤0.01% 1161
2018
Q1
Sell
-29
Closed -$1K 1856
2017
Q4
$1K Buy
+29
New +$601 ﹤0.01% 1678

Other funds holding PTEN

AssetMark Inc's PTEN Position: Q2 2026 in Review

AssetMark Inc increased its Patterson-UTI (PTEN) stake by 19% in Q2 2026, buying an estimated $49.5K and bringing the position to 28,230 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

AssetMark Inc first reported a position in PTEN in Q4 2017 and has held it in 18 quarters since. 100 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • AssetMark Inc held 28,230 shares of Patterson-UTI worth $259K as of Q2 2026.
  • AssetMark Inc bought 4,433 Patterson-UTI shares in Q2 2026, an estimated $49.5K.
  • Patterson-UTI made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1375 holding.
  • AssetMark Inc first reported a position in Patterson-UTI in Q4 2017 and has held it in 18 quarters since.
  • 100 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.